UniProt ID | GABPA_HUMAN | |
---|---|---|
UniProt AC | Q06546 | |
Protein Name | GA-binding protein alpha chain | |
Gene Name | GABPA | |
Organism | Homo sapiens (Human). | |
Sequence Length | 454 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcription factor capable of interacting with purine rich repeats (GA repeats). Necessary for the expression of the Adenovirus E4 gene.. | |
Protein Sequence | MTKREAEELIEIEIDGTEKAECTEESIVEQTYAPAECVSQAIDINEPIGNLKKLLEPRLQCSLDAHEICLQDIQLDPERSLFDQGVKTDGTVQLSVQVISYQGIEPKLNILEIVKPADTVEVVIDPDAHHAESEAHLVEEAQVITLDGTKHITTISDETSEQVTRWAAALEGYRKEQERLGIPYDPIQWSTDQVLHWVVWVMKEFSMTDIDLTTLNISGRELCSLNQEDFFQRVPRGEILWSHLELLRKYVLASQEQQMNEIVTIDQPVQIIPASVQSATPTTIKVINSSAKAAKVQRAPRISGEDRSSPGNRTGNNGQIQLWQFLLELLTDKDARDCISWVGDEGEFKLNQPELVAQKWGQRKNKPTMNYEKLSRALRYYYDGDMICKVQGKRFVYKFVCDLKTLIGYSAAELNRLVTECEQKKLAKMQLHGIAQPVTAVALATASLQTEKDN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Sumoylation | -----MTKREAEELI -----CCHHHHHHHE | 47.12 | - | |
23 | Phosphorylation | GTEKAECTEESIVEQ CCCCCCCCHHHHHCC | 34.00 | 27251275 | |
26 | Phosphorylation | KAECTEESIVEQTYA CCCCCHHHHHCCCCC | 26.21 | 27251275 | |
31 | Phosphorylation | EESIVEQTYAPAECV HHHHHCCCCCCHHHH | 14.24 | 27251275 | |
32 | Phosphorylation | ESIVEQTYAPAECVS HHHHCCCCCCHHHHH | 15.41 | 27251275 | |
39 | Phosphorylation | YAPAECVSQAIDINE CCCHHHHHHHHCCCC | 26.08 | 27251275 | |
62 | Phosphorylation | LEPRLQCSLDAHEIC HCHHHHCCCCHHHHH | 19.14 | 25849741 | |
218 | Phosphorylation | DLTTLNISGRELCSL CCEEEECCCHHHCCC | 30.63 | - | |
254 | O-linked_Glycosylation | LRKYVLASQEQQMNE HHHHHHHCHHHHHCC | 30.04 | 23301498 | |
264 | O-linked_Glycosylation | QQMNEIVTIDQPVQI HHHCCCEEECCCEEE | 25.21 | 23301498 | |
275 | O-linked_Glycosylation | PVQIIPASVQSATPT CEEEECCCCCCCCCC | 18.48 | 23301498 | |
278 | O-linked_Glycosylation | IIPASVQSATPTTIK EECCCCCCCCCCEEE | 31.77 | 23301498 | |
292 | Ubiquitination | KVINSSAKAAKVQRA EEECCCCHHHHCCCC | 51.31 | - | |
292 | Acetylation | KVINSSAKAAKVQRA EEECCCCHHHHCCCC | 51.31 | 25953088 | |
303 | Phosphorylation | VQRAPRISGEDRSSP CCCCCCCCCCCCCCC | 37.09 | 28355574 | |
308 | O-linked_Glycosylation | RISGEDRSSPGNRTG CCCCCCCCCCCCCCC | 53.88 | 23301498 | |
308 | Phosphorylation | RISGEDRSSPGNRTG CCCCCCCCCCCCCCC | 53.88 | 22496350 | |
309 | Phosphorylation | ISGEDRSSPGNRTGN CCCCCCCCCCCCCCC | 37.41 | 22496350 | |
309 | O-linked_Glycosylation | ISGEDRSSPGNRTGN CCCCCCCCCCCCCCC | 37.41 | 23301498 | |
349 | Sumoylation | VGDEGEFKLNQPELV CCCCCCEECCCHHHH | 42.07 | - | |
349 | Ubiquitination | VGDEGEFKLNQPELV CCCCCCEECCCHHHH | 42.07 | - | |
359 | Ubiquitination | QPELVAQKWGQRKNK CHHHHHHHHHCCCCC | 43.48 | 21890473 | |
364 | Acetylation | AQKWGQRKNKPTMNY HHHHHCCCCCCCCCH | 62.53 | 20167786 | |
366 | Ubiquitination | KWGQRKNKPTMNYEK HHHCCCCCCCCCHHH | 44.92 | - | |
368 | Phosphorylation | GQRKNKPTMNYEKLS HCCCCCCCCCHHHHH | 21.47 | 29083192 | |
371 | Phosphorylation | KNKPTMNYEKLSRAL CCCCCCCHHHHHHHH | 12.01 | 23403867 | |
373 | Sumoylation | KPTMNYEKLSRALRY CCCCCHHHHHHHHHH | 41.21 | - | |
373 | Acetylation | KPTMNYEKLSRALRY CCCCCHHHHHHHHHH | 41.21 | 20167786 | |
373 | Ubiquitination | KPTMNYEKLSRALRY CCCCCHHHHHHHHHH | 41.21 | - | |
373 | Sumoylation | KPTMNYEKLSRALRY CCCCCHHHHHHHHHH | 41.21 | - | |
379 | Methylation | EKLSRALRYYYDGDM HHHHHHHHHHHCCCE | 19.20 | - | |
380 | Phosphorylation | KLSRALRYYYDGDMI HHHHHHHHHHCCCEE | 13.76 | - | |
381 | Phosphorylation | LSRALRYYYDGDMIC HHHHHHHHHCCCEEE | 6.66 | - | |
382 | Phosphorylation | SRALRYYYDGDMICK HHHHHHHHCCCEEEE | 12.43 | - | |
405 | Phosphorylation | KFVCDLKTLIGYSAA EEEECHHHHHCCCHH | 30.79 | 22985185 | |
409 | Phosphorylation | DLKTLIGYSAAELNR CHHHHHCCCHHHHHH | 6.53 | 22985185 | |
424 | Acetylation | LVTECEQKKLAKMQL HHHHHHHHHHHHHHH | 27.71 | 25953088 | |
424 | Ubiquitination | LVTECEQKKLAKMQL HHHHHHHHHHHHHHH | 27.71 | - | |
428 | Ubiquitination | CEQKKLAKMQLHGIA HHHHHHHHHHHCCCC | 37.30 | - | |
439 | Phosphorylation | HGIAQPVTAVALATA CCCCHHHHHHHHHHH | 23.30 | 27307780 | |
445 | Phosphorylation | VTAVALATASLQTEK HHHHHHHHHHHHHCC | 20.03 | 27307780 | |
447 | Phosphorylation | AVALATASLQTEKDN HHHHHHHHHHHCCCC | 19.36 | 22817901 | |
450 | Phosphorylation | LATASLQTEKDN--- HHHHHHHHCCCC--- | 50.74 | 27307780 | |
452 | Ubiquitination | TASLQTEKDN----- HHHHHHCCCC----- | 66.99 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GABPA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GABPA_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GABPA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SP1_HUMAN | SP1 | physical | 11237613 | |
SP3_HUMAN | SP3 | physical | 11237613 | |
ATF1_HUMAN | ATF1 | physical | 10585419 | |
MED1_HUMAN | MED1 | physical | 16574658 | |
EP300_HUMAN | EP300 | physical | 17304221 | |
HDAC1_HUMAN | HDAC1 | physical | 17304221 | |
A4_HUMAN | APP | physical | 21832049 | |
GABP1_HUMAN | GABPB1 | physical | 11953439 | |
TYY1_HUMAN | YY1 | physical | 11953439 | |
PINX1_HUMAN | PINX1 | physical | 21988832 | |
CUTC_HUMAN | CUTC | physical | 22863883 | |
DBLOH_HUMAN | DIABLO | physical | 22863883 | |
RB3GP_HUMAN | RAB3GAP1 | physical | 22863883 | |
RBGPR_HUMAN | RAB3GAP2 | physical | 22863883 | |
SEN34_HUMAN | TSEN34 | physical | 22863883 | |
EP300_HUMAN | EP300 | physical | 16581781 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...